Boise and Meridian, Idaho About Glossary Questions Questions about an appointment? (208) 706-4650
Shelley K. Perkins, MD Breast Surgery

Home › Diagnosis and treatment › Triple negative

Diagnosis & treatment

Triple negative breast cancer

Triple negative breast cancer tests negative for all three receptors: estrogen, progesterone, and HER2. There is no hormone switch and no HER2 switch to turn off, so chemotherapy does the work, and giving it first shows how well it worked.

What triple negative breast cancer is

breast cancer tests negative for all three receptors: estrogen, progesterone, and HER2. There is no hormone switch and no HER2 switch to turn off, so the medicines that do that work in other types have nothing to act on. It tends to be higher grade and to grow faster, which is exactly why it responds well to chemotherapy, which works best on fast-dividing cells. It is more common in younger women, in Black women, and in people who carry a gene change.

What usually happens next with triple negative breast cancer, in order

  1. Genetic testing, offered to everyone with this type regardless of age or family history, because the result can change both surgery and medicine.
  2. Medicine first, for most. For cancers larger than about 2 cm or with a positive node, comes before surgery, usually with an medicine, pembrolizumab, added. The course runs about five to six months. A clip is placed in the tumor first so it can be found.
  3. Surgery. Lumpectomy or mastectomy, with the nodes checked. How much cancer remains is the most useful information about the future that anyone will have, and it decides the next step.
  4. After surgery. If no cancer remained, immunotherapy is completed on its own. If cancer remained, an oral chemotherapy pill or, for people with a BRCA change, a is usually added for a period afterward.
  5. Radiation, on the same rules as other types.

For small triple negative cancers with clear nodes, surgery may come first, followed by chemotherapy decided from the final report.

Choices you will be asked about with triple negative breast cancer

Lumpectomy or mastectomy, decided after the medicine has done its work. If a BRCA change is found, whether to remove both breasts, which is a personal decision rather than a medical necessity. Fertility preservation before chemotherapy. A clinical trial, since this is the type where the most new treatments are being studied.

In plain terms

Triple negative is the type where chemotherapy is the main event, and giving it first shows how well it worked. A cancer that disappears completely under treatment has told you something no scan can.

Questions to bring to your appointment

These are built for triple negative breast cancer. The report decoder narrows the list further from your own report, and the print button there puts it on paper with room to write. Bring someone with you if you can; two sets of ears hear more than one.

Where this comes from

Sources, checked 9 September 2026

This page is written in plain language from the current NCCN Guidelines for Patients: Invasive Breast Cancer (2026 edition, based on NCCN Guidelines for Breast Cancer version 2.2026), which Dr. Perkins shared as the reference for this page and which is free to read at NCCN.org/patientguidelines, along with NCCN's separate patient guides for DCIS and for metastatic breast cancer. NCCN's material is copyrighted and nothing here reproduces it; readers who want the full detail should go to the source. Breastcancer.org publishes a free guide to reading a pathology report, updated June 2026, at breastcancer.org/pathology-report. Margin definitions follow the Society of Surgical Oncology and American Society for Radiation Oncology consensus statements for invasive cancer (2014) and DCIS (2016). Receptor cutoffs follow the American Society of Clinical Oncology and College of American Pathologists guidelines. Staging follows the American Joint Committee on Cancer, eighth edition. Every clinical statement on this page is listed on the site's verification ledger, and Dr. Perkins read the site on 13 September 2026.

This page is education. It does not diagnose, and the summary it builds is not a treatment plan. Your plan is made with your own care team from your own results.

Published 7 September 2026 as part of the guide; a page of its own since 9 September 2026.

Call the office